T-cell co-stimmulatory molecules are upregulated on intestinal macrophages from inflammatory bowel disease mucosa

European Journal of Gastroenterology and Hepatology

Volumn 11, Issue 10, 1999, Pages 1105-1111

  Rogler, Gerhard ^a   Hausmann, Martin ^b   Spöttl, Tanja ^b   Vogl, Daniela ^b   Aschenbrenner, Elisabeth ^b   Andus, Tilo ^b   Falk, Werner ^b   Schölmerich, Jürgen ^b   Gross, Volker ^b  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b NONE

Author keywords

B7 1; B7 2; Co stimulation molecules; Inflammation; Inflammatory bowel disease; Intestinal macrophages

Indexed keywords

B7 ANTIGEN; CD14 ANTIGEN; CD33 ANTIGEN; CD86 ANTIGEN; CELL MARKER;

ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; ARTICLE; CLINICAL ARTICLE; COLON; CONTROLLED STUDY; CROHN DISEASE; ENTERITIS; FLOW CYTOMETRY; FLUORESCENCE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; INTESTINE BIOPSY; INTESTINE CELL; INTESTINE MUCOSA; LYMPHOCYTE ACTIVATION; MACROPHAGE; PRIORITY JOURNAL; T LYMPHOCYTE; ULCERATIVE COLITIS;

EID: 0033364347     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042737-199910000-00006     Document Type: Article

References (41)

1. 1 Janeway CJ, Bottomly K. Signals and signs for lymphocyte responses. Cell 1994; 76:275-285.
2. 2 Allison JP. CD28-B7 interactions in T-cell activation. Curr Opin Immunol 1994; 6:414-419.
3. 3 Robey E, Allison JP. T-cell activation: integration of signals from the antigen receptor and costimulatory molecules. Immunol Today 1995; 16:306-310.
4. 4 Lindsey PS, Ledbetter JA. The role of the CD28 receptor during T-cell responses to antigen. Annu Rev Immunol 1993; 11:191-212.
5. 5 Caux C, Vanbervliet B, Massacrier C, Azuma M, Okumura K, Lanier LL, Banchereau J. B70/B7-2 is identical to CD86 and is the major functional ligand for CD28 expressed on dendritic cells. J Exp Med 1994; 180:1841-1847.
6. 6 Engel P, Gribben JG, Freemen GJ, Zhou LJ, Nozawa Y, Abe M, et al. The B7-2 (B70) costimulatory molecule expressed by monocytes and activated B lymphocytes is the CD 86 differentiation antigen. Blood 1994; 84:1402-1407.
7. 7 Harlan DM, Abe R, Le KP, June CH. Potential roles of the B7 and CD28 receptor families in autoimmunity and immune evasion. Clin Immunol Immunopathol 1995; 75:99-111.
8. 8 Guerder S, Meyerhoff J, Flavell R. The role of the T-cell costimulator B7-1 in autoimmunity and the induction and maintenance of tolerance to peripheral antigen. Immunity 1994; 1:155-166.
9. 9 Kuchroo VK, Das MP, Brown JA, Ranger AM, Zamvil SS, Sobel RA, et al. B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy. Cell 1995; 80:707-718.
10. 10 Lenschow DJ, Bluestone JA. T-cell co-stimulation and in vivo tolerance. Curr Opin Immunol 1993; 5:747-752.
11. 11 Thompson CB. Distinct roles for the costimulatory ligands B7-1 and B7-2 in T-helper cell differentiation. Cell 1995; 81:979-982.
12. 12 Lee SH, Starkey PM, Gordon S. Quantitative analysis of total macrophage content in adult mouse tissues. Immunochemical studies with monoclonal antibody F4/80. J Exp Med 1985; 161:475-489.
13. 13 Pavli P, Doe WF. Intestinal macrophages. In: Inflammatory Bowel Disease. MacDermott RP, Stenson WF (editors). New York: Elsevier; 1992. pp. 177-188.
14. 14 Donnellan WL. The structure of the colonic mucosa. The epithelium and subepithelial reticulohistiocytic complex. Gastroenterology 1965; 49:496-514.
15. 15 Rogler G, Hausmann M, Vogl D, Aschenbrenner E, Andus T, Falk W, et al. Isolation and phenotypic characterization of colonic macrophages. Clin Exp Immunol 1998; 112:205-215.
16. 16 Andus T, Rogler G, Daig R, Falk W, Schölmerich J, Gross V. The role of macrophages. In: Inflammatory Bowel Disease. Tygat GNJ, Bartelsman JFWM, van Deventer SJH (editors). Dordrecht, Boston, London: Kluwer; 1995. pp. 281-297.
17. + population of monocytes in inflammatory bowel disease mucosa - implications for pathogenesis. Clin Exp Immunol 1995; 100:291-297.
18. 18 Mahida YR, Patel S, Gionchetti P, Vaux D, Jewell DP. Macrophage subpopulations in lamina propria of normal colon and inflamed colon and terminal ileum. Gut 1989; 30:826-834.
19. 19 Duchmann R, Kaiser I, Hermann E, Mayet W, Ewe K, Meyer zum Büschenfelde KH. Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD). Clin Exp Immunol 1995; 102:448-455.
20. 20 Macpherson A, Khoo U, Forgacs I, Philpott-Howard JIB. Mucosal antibodies in inflammatory bowel disease are directed against intestinal bacteria. Gut 1996; 38:365-375.
21. 21 Chelen CJ, Fang Y, Freeman GJ, Secrist H, Marshall JD, Hwang PT, et al. Human alveolar macrophages present antigen ineffectively due to defective expression of B7 costimulatory cell surface molecules. J Clin Invest 1995; 95:1415-1421.
22. 22 Bull DM, Bookman MA. Isolation and functional characterization of human intestinal mucosal lymphoid cells. J Clin Invest 1977; 59:966-974.
23. 23 Rutgeerts P, Geboes K, Peeters M, Hiele M, Penninckx F, Aerts R, et al. Effect of fecal stream diversion on recurrence of Crohn's disease in the neoterminal ileum. Lancet 1991; 338:771-774.
24. 24 Banerjee AK, Peters TJ. Crohn's disease and NSAID enteropathy - a unifying model. Gastroenterology 1990; 99:1190-1192.
25. 25 Kent TH, Cardelli RM, Stamler FW. Small intestinal ulcers and intestinal flora in rats given indomethacin. Am J Pathol 1969; 54:237-249.
26. 26 Sartor RB, Cromartie WJ, Powell DW, Schwab JH. Granulomatous enterocolitis induced in rats by purified bacterial cell wall fragments. Gastroenterology 1985; 89:587-595.
27. 27 Rath HC, Herfarth HH, Ikeda JS, Grenther WB, Hamm TE Jr, Balish E, et al. Normal luminal bacteria, especially Bacteroides species, mediate chronic colitis, gastritis, and arthritis in HLA-B27/human beta2 microglobulin transgenic rats. J Clin Invest 1996; 98:945-953.
28. 28 Pritzer U, Schönharr A, Fleischer B, Hermann E, Meyer zum Büschenfelde KH. Reactivity of infiltrating T lymphocytes with micobial antigens in Crohn's disease. Lancet 1991; 338:1238-1239.
29. 29 Liu ZX, Hiwatashi N, Noguchi M, Toyota T. Increased expression of costimulatory molecules on peripheral blood monocytes in patients with Crohn's disease. Scand J Gastroenterol 1997; 32:1241-1246.
30. 30 Kim SK, Reed DS, Olson S, Schnell MJ, Rose JK, Morton PA, Lefrancois L. Generation of mucosal cytotoxic T cells against soluble protein by tissue-specific environmental and costimulatory signals. Proc Natl Acad Sci USA 1998; 95:10814-10819.
31. 31 Gardby E, Lane P, Lycke NY. Requirements for B7-CD28 costimulation in mucosal IgA responses: paradoxes observed in CTLA4-H gamma 1 transgenic mice. J Immunol 1998; 161:49-59.
32. 32 Rugtveit J, Bakka A, Brandtzaeg P. Differential distribution of B7.1 (CD80) and B7.2 (CD86) costimulatory molecules on mucosal macrophage subsets in human inflammatory bowel disease (IBD). Clin Exp Immunol 1997; 110:104-113.
33. 33 Rugtveit J, Nilsen EM, Bakka A, Carlsen H, Brandtzaeg P, Scott H. Cytokine profiles differ in newly recruited and resident subsets of mucosal macrophages from inflammatory bowel disease. Gastroenterology 1997; 112:1493-1505.
34. 34 Hara J, Ohtani H, Matsumoto T, Nakamura S, Kitano A, Arakawa T, et al. Expression of costimulatory molecules B7-1 and B7-2 in macrophages and granulomas of Crohn's disease: demonstration of cell-to-cell with T lymphocytes. Lab Invest 1997; 77:175-184.
35. 35 Sartor RB. Cytokines in intestinal inflammation: pathophysiological and clinical considerations. Gastroenterology 1994; 106:533-539.
36. - T-cells in inflammatory bowel disease. Gastroenterology 1991; 101:1594-1605.
37. 37 Brynskov J, Tvede N, Andersen CB, Vilien M. Increased concentrations of interleukin 1β, interleukin-2, and soluble interleukin-2 receptors in endoscopical mucosal biopsy specimens with active inflammatory bowel disease. Gut 1992; 33:55-58.
38. 38 Breese EJ, Braegger CP, Corrigan CJ, Walker SJ, MacDonald TT. Interleukin-2 and interferon-γ-secreting T-cells in normal and diseased human intestinal mucosa. Immunology 1993; 78:127-131.
39. 39 Niesser M, Volk BA. Altered Th1/Th2 cytokine profiles in the intestinal mucosa of patients with inflammatory bowel disease as assessed by quantitative reversed transcribed polymerase chain reaction (RT-PCR). Clin Exp Immunol 1995; 101:428-435.
40. + lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn's disease LP cells manifest increased secretion of IFN-γ, whereas ulcerative colitis LP cells manifest increased secretion of IL-5. J Immunol 1996; 157:1261-1270.
41. 41 Brown DR, Green JM, Moskowitz NH, Davis M, Thompson CB, Reiner SL. Limited role of CD28-mediated signals in T helper subset differentiation. J Exp Med 1996; 184:803-810.